株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

人工心血管置換装置:医療機器のパイプライン評価

Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2019

発行 GlobalData 商品コード 350920
出版日 ページ情報 英文 290 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.33円で換算しております。
Back to Top
人工心血管置換装置:医療機器のパイプライン評価 Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2019
出版日: 2019年12月24日 ページ情報: 英文 290 Pages
概要

当レポートでは、人工心血管置換装置のパイプライン製品について調査分析し、開発段階別の比較分析に焦点を当てて、パイプライン製品の開発に従事している主要企業、進行中の臨床試験に関する情報なども含めて、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

  • 人工心血管置換装置の概要

第3章 開発中の製品

  • 人工心血管置換装置 - パイプライン製品:開発段階別
  • 人工心血管置換装置 - パイプライン製品:セグメント別
  • 人工心血管置換装置 - パイプライン製品:地域別
  • 人工心血管置換装置 - パイプライン製品:規制別
  • 人工心血管置換装置 - パイプライン製品:承認予定日別
  • 人工心血管置換装置 - 進行中の臨床試験

第4章 人工心血管置換装置 - 開発中のパイプライン製品:企業別

  • 人工心血管置換装置企業 - パイプライン製品:開発段階別
  • 人工心血管置換装置 - パイプライン製品:開発段階別

第5章 人工心血管置換装置企業と製品の概要

  • 4tech Cardio Ireland Limited
  • Agamit Medical Ltd.
  • Ample Medical Inc.
  • Amsel Medical Corporation
  • Aporo Biomedical, Inc.
  • Arbor Surgical Technologies, Inc.
  • BioStable Science & Engineering, Inc.
  • BioVentrix, Inc.
  • CARAG AG
  • Cardica, Inc.
  • Cardiosolutions, Inc.
  • Cardious, Inc.
  • Celyad SA
  • Children's Hospital Boston
  • Cierra, Inc. (休止中)
  • CoAptus Medical Corporation
  • CollPlant Ltd.
  • coramaze technologies GmbH
  • Cordis Corporation
  • Coroneo Inc.、など

第6章 人工心血管置換装置 - 最近の動向

第7章 付録

図表

図表

List of Tables

  • Table 1: Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development 18
  • Table 2: Cardiovascular Prosthetic Devices - Pipeline Products by Segment 19
  • Table 3: Cardiovascular Prosthetic Devices - Pipeline Products by Territory 20
  • Table 4: Cardiovascular Prosthetic Devices - Pipeline Products by Regulatory Path 21
  • Table 5: Cardiovascular Prosthetic Devices - Pipeline Products by Estimated Approval Date 22
  • Table 6: Cardiovascular Prosthetic Devices - Ongoing Clinical Trials 23
  • Table 7: Cardiovascular Prosthetic Devices Companies - Pipeline Products by Stage of Development 24
  • Table 8: Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development 27
  • Table 9: 4Tech Cardio Ireland Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 10: TriCinch Coil Tricuspid Valve Repair System - Product Status 30
  • Table 11: TriCinch Coil Tricuspid Valve Repair System - Product Description 30
  • Table 12: 4Tech Cardio Ireland Ltd - Ongoing Clinical Trials Overview 31
  • Table 13: TriCinch Coil Tricuspid Valve Repair System - Clinical Trial Evaluation of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System 32
  • Table 14: TriCinch Coil Tricuspid Valve Repair System - Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System 32
  • Table 15: TriCinch Coil Tricuspid Valve Repair System - Early Feasibility Study of TriCinch Coil Tricuspid Valve Repair System 32
  • Table 16: TriCinch Coil Tricuspid Valve Repair System - International Multisite Transcatheter Tricuspid Valve Therapies Registry 33
  • Table 17: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 18: TriClip Device - Product Status 34
  • Table 19: TriClip Device - Product Description 34
  • Table 20: Abbott Vascular Inc - Ongoing Clinical Trials Overview 35
  • Table 21: TriClip Device - Clinical Trial to Evaluate Cardiovascular Outcomes in Patients Treated with the Tricuspid Valve Repair System Pivotal 36
  • Table 22: TriClip Device - Trial to Evaluate Treatment with Abbott Transcatheter Clip Repair System in Patients with Moderate or Greater Tricuspid Regurgitation (TRILUMINATE) 36
  • Table 23: Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 24: Epygon - Product Status 37
  • Table 25: Epygon - Product Description 37
  • Table 26: Kalios - Product Status 38
  • Table 27: Kalios - Product Description 38
  • Table 28: Affluent Medical SA - Ongoing Clinical Trials Overview 39
  • Table 29: Kalios - OPTIMISE II: Optimisation of Surgical Repair for Treating Insufficiency of the Mitral Valve - Safety and Effectiveness Evaluation 40
  • Table 30: Ample Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 31: PS3 System - Product Status 41
  • Table 32: PS3 System - Product Description 41
  • Table 33: Ancora Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 34: AccuCinch Ventriculoplasty System - Product Status 42
  • Table 35: AccuCinch Ventriculoplasty System - Product Description 42
  • Table 36: Ancora Heart Inc - Ongoing Clinical Trials Overview 43
  • Table 37: AccuCinch Ventriculoplasty System - A Study of Percutaneous Repair of Functional Mitral Regurgitation Using the Ancora Heart, Inc. AccuCinch Ventricular Repair System - The CINCH-2 Study 44
  • Table 38: AccuCinch Ventriculoplasty System - An Early Feasibility Evaluation of the AccuCinch Ventricular Repair System in Patients with Heart Failure and Reduced Ejection Fraction (HFrEF) - The CorCinch-HFrEF Study 44
  • Table 39: AccuCinch Ventriculoplasty System - An Early Feasibility Study of the AccuCinch Ventricular Repair System in Patients with Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation - The CorCinch-PMVI Study 44
  • Table 40: AccuCinch Ventriculoplasty System - Early Feasibility Study of the AccuCinch Ventricular Repair System 45
  • Table 41: AccuCinch Ventriculoplasty System - Safety and Performance Evaluation of the AccuCinch Ventricular Repair System for Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study 45
  • Table 42: Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 43: Patent Foramen Ovale Closure Device - Product Status 46
  • Table 44: Patent Foramen Ovale Closure Device - Product Description 46
  • Table 45: AuriGen Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 46: Trans-Septal Implant - Product Status 47
  • Table 47: Trans-Septal Implant - Product Description 47
  • Table 48: BioStable Science & Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 49: HAART 200 Aortic Annuloplasty Device - Product Status 48
  • Table 50: HAART 200 Aortic Annuloplasty Device - Product Description 48
  • Table 51: BioStable Science & Engineering, Inc. - Ongoing Clinical Trials Overview 49
  • Table 52: HAART 200 Aortic Annuloplasty Device - Safety and Performance of Aortic Valve Repair Using the HAART Aortic Annuloplasty Devices - A Registry Study 50
  • Table 53: BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 54: Revivent-TC System - Product Status 51
  • Table 55: Revivent-TC System - Product Description 51
  • Table 56: BioVentrix Inc - Ongoing Clinical Trials Overview 52
  • Table 57: Revivent-TC System - Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy 53
  • Table 58: Revivent-TC System - Clinical Study of the BioVentrix Revivent TC System for Treatment of Left Ventricular Aneurysms (ALIVE) 53
  • Table 59: Revivent-TC System - Phase II Study of the BioVentrix PliCath HF System for the Treatment of Ischemic Cardiomyopathy 53
  • Table 60: Revivent-TC System - Randomized Evaluation and Verification of Ventricular Enhancement: The REVIVE-HF Study 54
  • Table 61: CARAG AG Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 62: Carag BioResorbable Septal Occluder - Product Status 55
  • Table 63: Carag BioResorbable Septal Occluder - Product Description 55
  • Table 64: CARAG AG - Ongoing Clinical Trials Overview 56
  • Table 65: Carag BioResorbable Septal Occluder - Multi Centre, International, Post Market Registry to Monitor the Clinical Performance and Safety of an Atrial Septal Closure Device with Bioresorbable Framework in Patients with Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO) in Routine Clinical Use 57
  • Table 66: Cardiac Dimensions Inc Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 67: CARILLON Mitral Contour System - Product Status 58
  • Table 68: CARILLON Mitral Contour System - Product Description 58
  • Table 69: Cardiac Dimensions Inc - Ongoing Clinical Trials Overview 59

List of Figures

  • Figure 1: Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development 18
  • Figure 2: Cardiovascular Prosthetic Devices - Pipeline Products by Segment 19
  • Figure 3: Cardiovascular Prosthetic Devices - Pipeline Products by Territory 20
  • Figure 4: Cardiovascular Prosthetic Devices - Pipeline Products by Regulatory Path 21
  • Figure 5: Cardiovascular Prosthetic Devices - Pipeline Products by Estimated Approval Date 22
  • Figure 6: Cardiovascular Prosthetic Devices - Ongoing Clinical Trials 23
目次
Product Code: GDME0894EPD

GlobalData's Medical Devices sector report, "Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Cardiovascular Prosthetic Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiovascular Prosthetic Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiovascular Prosthetic Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiovascular Prosthetic Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiovascular Prosthetic Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 8
  • 1.2 List of Figures 15

2 Introduction 17

  • 2.1 Cardiovascular Prosthetic Devices Overview 17

3 Products under Development 18

  • 3.1 Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development 18
  • 3.2 Cardiovascular Prosthetic Devices - Pipeline Products by Segment 19
  • 3.3 Cardiovascular Prosthetic Devices - Pipeline Products by Territory 20
  • 3.4 Cardiovascular Prosthetic Devices - Pipeline Products by Regulatory Path 21
  • 3.5 Cardiovascular Prosthetic Devices - Pipeline Products by Estimated Approval Date 22
  • 3.6 Cardiovascular Prosthetic Devices - Ongoing Clinical Trials 23

4 Cardiovascular Prosthetic Devices - Pipeline Products under Development by Companies 24

  • 4.1 Cardiovascular Prosthetic Devices Companies - Pipeline Products by Stage of Development 24
  • 4.2 Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development 27

5 Cardiovascular Prosthetic Devices Companies and Product Overview 30

  • 5.1 4Tech Cardio Ireland Ltd Company Overview 30
    • 5.1.1 4Tech Cardio Ireland Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.2 Abbott Vascular Inc Company Overview 34
    • 5.2.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.3 Affluent Medical SA Company Overview 37
    • 5.3.1 Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.4 Ample Medical Inc Company Overview 41
    • 5.4.1 Ample Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.5 Ancora Heart Inc Company Overview 42
    • 5.5.1 Ancora Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.6 Aporo Biomedical, Inc. (Inactive) Company Overview 46
    • 5.6.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.7 AuriGen Medical Ltd Company Overview 47
    • 5.7.1 AuriGen Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.8 BioStable Science & Engineering, Inc. Company Overview 48
    • 5.8.1 BioStable Science & Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.9 BioVentrix Inc Company Overview 51
    • 5.9.1 BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.10 CARAG AG Company Overview 55
    • 5.10.1 CARAG AG Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.11 Cardiac Dimensions Inc Company Overview 58
    • 5.11.1 Cardiac Dimensions Inc Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.12 Cardiosolutions Inc Company Overview 61
    • 5.12.1 Cardiosolutions Inc Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.13 Celyad SA Company Overview 62
    • 5.13.1 Celyad SA Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.14 Children's Hospital Boston Company Overview 65
    • 5.14.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.15 Cierra, Inc. (Inactive) Company Overview 68
    • 5.15.1 Cierra, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.16 Collplant Biotechnologies Ltd Company Overview 69
    • 5.16.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.17 coramaze technologies GmbH Company Overview 70
    • 5.17.1 coramaze technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.18 CoreMedic AG Company Overview 71
    • 5.18.1 CoreMedic AG Pipeline Products & Ongoing Clinical Trials Overview 71
  • 5.19 CUBE SRL Company Overview 74
    • 5.19.1 CUBE SRL Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.20 Daidalos Solutions BV Company Overview 75
    • 5.20.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 75

6 Cardiovascular Prosthetic Devices- Recent Developments 182

  • 6.1 Nov 20, 2019: FDA approves BioVentrix's Revivent TC system 182
  • 6.2 Nov 20, 2019: LivaNova to restructure its heart valve business line and End Caisson Transcatheter Mitral Valve Replacement Program 182
  • 6.3 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 183
  • 6.4 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 185
  • 6.5 Nov 12, 2019: Cook Medical's leadership updates in Asia-pacific reinforce focus on growth and physician relationships 186

7 Appendix 287

  • 7.1 Methodology 287
  • 7.2 About GlobalData 290
  • 7.3 Contact Us 290
  • 7.4 Disclaimer 290
Back to Top